{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage",
        "Inverse exposure",
        "Synthetic replication",
        "Use of derivatives (swaps)",
        "Daily rebalancing and compounding effects",
        "High risk profile (risk class 7/7)",
        "Potential counterparty and collateral risk",
        "Short recommended holding period (1 day)",
        "Complex payoff structure"
    ],
    "classification": "complex",
    "supporting_data": "The product is a -3x leveraged inverse ETP on the iShares MSCI South Korea ETF, explicitly described as providing -3 times the daily performance of the reference ETF. It uses derivatives, including swaps, to achieve synthetic replication rather than physical holding of underlying securities. The product involves daily leverage rebalancing, leading to compounding effects that can significantly deviate returns over holding periods longer than one day. The KID states a very high risk class (7/7), no capital protection, and a recommended holding period of only one day, indicating complexity and risk unsuitable for typical retail investors. The product is collateralised but exposes investors to counterparty and collateral risks inherent in synthetic replication and securities lending. The structure and risks require advanced understanding beyond basic financial literacy, consistent with MiFID II criteria for complex instruments. According to MiFID II Article 25(4)(a)(vi) and Article 57 of the Delegated Regulation, such use of derivatives integral to the investment strategy, leverage beyond UCITS limits, synthetic replication, and complex payoff profiles classify the product as complex. The product is not UCITS compliant and is an Exchange Traded Product (ETP), not an ETF. Therefore, it fails the non-complex criteria and requires an appropriateness assessment before sale to retail clients."
}